Artha Sootra - Company Dashboard

Governance Classic Home

Sanofi Consumer Healthcare India LtdPharmaceuticalsINE0UOS01011Standalone₹3475.50+46.70 (+1.36%)

Valuation

Market Cap₹8.00K Cr

TTM PE28.60x

Forward PE28.13x

PEG5.55

Book Value₹111.59

P/B31.12x

TTM EPS₹121.44

Fwd EPS₹123.43

TTM Revenue₹979.00 Cr

TTM PAT₹279.70 Cr

TTM EBITDA₹369.60 Cr

TTM EBIT₹356.60 Cr

Last Qtr PAT₹76.60 Cr

Last Qtr EBITDA₹101.70 Cr

Last Qtr EBIT₹98.60 Cr

Profitability

ROE108.83%

ROCE147.00%

TTM NPM28.57%

TTM EBITDA %37.75%

Curr OPM28.64%

Last OPM28.43%

Curr NPM—

Last NPM—

Curr EPS₹33.26

Last EPS₹29.87

Balance sheet

Equity₹23.00 Cr

Reserve₹234.00 Cr

Total Debt₹0.00 Cr

D/E0.00x

Interest %0.39%

Curr Interest₹0.30 Cr

Price / range

Close₹3472.60

vs 52W High-33.92%

vs 52W Low+9.61%

MA50—

MA200—

Returns

1D-0.67%

1W+4.51%

1M-8.04%

3M-23.33%

6M-26.63%

1Y-28.76%

2Y-28.61%

3Y—

5Y—

Diwali-23.51%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	130.40	3.70%
DIVISLAB	10037.50	₹2.66L Cr	90.60	17.55%
TORNTPHARM	4738.50	₹1.60L Cr	83.32	11.07%
LAURUSLABS	2323.80	₹1.25L Cr	120.09	17.24%
ZYDUSLIFE	1188.10	₹1.20L Cr	38.84	11.33%
DRREDDY	1374.00	₹1.15L Cr	413.86	2.50%
CIPLA	1402.00	₹1.13L Cr	42.73	7.49%
MANKIND	2537.90	₹1.05L Cr	45.48	13.10%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25
Revenue	263.10+12.5%	235.70	229.20	251	233.90
Other Income	4.40	6.30	5.60	4.60	3
Total Income	267.50+12.9%	242	234.80	255.60	236.90
Interest	0.30	0.40	0.50	0.50	0.60
Expenditure	-164.80-7.9%	-150.10	-144.10	-165.10	-152.80
PBDT	0	0	0	0	0
EBITDA	101.70+19.6%	89.30	88.80	89.80	85
Depreciation	-3.10	-3.30	-3.20	-3.40	-3.30
EBIT	98.60+20.7%	86	85.60	86.40	81.70
PBT	102.70+22.1%	91.90	90.70	90.50	84.10
Tax	-26.10	-23.10	-22.90	-24	-21.20
Equity	23	23	23	0	0
OPM	38.39	37.98	38.63	36.06	35.96
Net Profit	76.60+21.8%	68.80	67.80	66.50	62.90
NPM	28.64	28.43	28.88	26.49	26.89
EPS	33.26+21.8%	29.87	29.44	28.87	27.31

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	75	19 Jun 2026
2025	Final Dividend	55	28 Apr 2025
2025	Final Dividend	55	17 Apr 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split